NASDAQ: UTHRUnited Therapeutics Corp Earnings Dates, Reports, Calls
United Therapeutics earnings were $1.3B for the trailing 12 months ending Jun 30, 2026, with 9.2% growth year over year. The latest UTHR earnings report on Jun 30, 2026 announced Q2 2026 earnings of $333.0M, up 21.1% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, UTHR reported annual earnings of $1.3B, with 11.7% growth. The next UTHR earnings date is Nov 4, 2026.
UTHR past earnings growth
How has UTHR's earnings growth performed historically?
Company
9.25%
Industry
17.64%
Market
92.92%
UTHR's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
UTHR's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
UTHR's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance
UTHR earnings history
Current Revenue
$3.2B
Current Earnings
$1.3B
Current Profit Margin
41.6%
UTHR's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance
UTHR Return on Equity
Current Company
20.2%
Current Industry
-13.6%
Current Market
31.1%
UTHR's Return on Equity (20.2%)... subscribe to Premium to read more.
High Return on Equity Performance
UTHR Return on Assets
Current Company
18%
Current Industry
-10.2%
UTHR is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance
Be the first to know when UTHR announces earnings.
UTHR Return on Capital Employed
Current Company
23.97%
Current Industry
-6.7%
UTHR has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance
UTHR vs Biotech Stocks
UTHR earnings dates
- Next earnings date
- Nov 4, 2026
United Therapeutics Earnings Reports & History FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.